Clinical Trials Directory

Trials / Completed

CompletedNCT04802317

Intestinal Microbiota in COPD and Asthma

Identifying the Relationship Between the Features of the Composition and Functioning of the Intestinal Microbiota With the Course of Chronic Obstructive Pulmonary Disease and Asthma (MicrObAs)

Status
Completed
Phase
Study type
Observational
Enrollment
149 (actual)
Sponsor
National Medical Research Center for Therapy and Preventive Medicine · Other Government
Sex
All
Age
18 Years – 74 Years
Healthy volunteers
Accepted

Summary

The composition of the intestinal microbiota, the level of lipopolysaccharides, TMAO in the blood, and other parameters of patients with COPD (n=50), asthma (n=50) and the control (n=40) will be assessed as factors associated with exacerbations and respiratory symptoms in the prospective study (12 months).

Detailed description

The patients from "Biobank of blood and feces for the development of a clinical and biological platform as a basis for an innovative approach to the prevention of chronic non-infectious diseases based on the composition of the intestinal microbiota" study will be included (cross-sectional study). The protocol of the above study included the assessment of socio-demographic, anthropometric data, clinical blood pressure (BP), ECG, blood tests, fecal microbiota studies, spirometry data, diet questionnaire. ABPM, HBP, other questionnaires (mMRC, CAT, ACQ-5, GMBQ) will be added to initial data (=visit 1). Than the four visits (2-5th visits) in 3 each months will be performed to assess respiratory symptoms, exacerbations of COPD/asthma, respiratory infections, therapy, BP, and other parameters. The standard statistical methods will be used.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIdentification of the composition of the intestinal microbiotaIdentification of the composition of the intestinal microbiota

Timeline

Start date
2020-06-23
Primary completion
2023-06-30
Completion
2023-12-05
First posted
2021-03-17
Last updated
2023-12-06

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04802317. Inclusion in this directory is not an endorsement.